JPRN-jRCTs061210072招募中未知
Development of immunosuppressive therapy with teprenone to reduce the severity of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
Fujii Keiko0 个研究点目标入组 80 人开始时间: 2022年1月27日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 15age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Allogeneic hematopoietic stem cell transplant recipients
排除标准
- •(1) Under 15 years old
- •(2) With mental illness or psychiatric symptoms
- •(3) Pregnancy, lactation
- •(4) Severe allergy to teprenone
研究者
相似试验
已完成
不适用
First-Line Immunosuppressive Therapies for Acquired Hemophilia A: A 25-year Cohort Experience and Network Meta-Analysis Short title: First-Line Immunosuppressive Therapies in AHAAcquired hemophiliaAcquired hemophilia AComplete remissionImmunosuppressive treatmentRelapseTCTR20240405005/A76
招募中
不适用
Development of new approaches for immunotherapy of non-small cell lung cancerC34Malignant neoplasm of bronchus and lungDRKS00029641Molekulare PneumologieUniversitätsklinikum Erlangen
进行中（未招募）
不适用
Immunosoppressive protocol based on everolimus and calcineurin inhibitor low doses in lung transplant recipients with moderate-severe kidney disease after standard immnuotherapy. - NDkidney disease after pulmonary transplantMedDRA version: 9.1Level: LLTClassification code 10038474Term: Renal insufficiencyEUCTR2008-000102-36-ITOSPEDALE POLICLINICO S. MATTEO
已完成
不适用
A pharmacogenetic approach to immunosuppression for renal transplantatioISRCTN39668614Record Provided by the NHSTCT Register - 2007 Update - Department of Health (UK)100
已完成
不适用
Study of combination immunosuppressive therapy in primary sclerosing cholangitis - A multicenter study for combination immunosuppressive therapy with mizoribine and azathioprinePrimary sclerosing cholangitisJPRN-UMIN000029482Osaka General Medical Center6